Regev E - Search Results

1

The safety of sodium glucose transporter 2 inhibitors and trends in clinical and hemodynamic parameters in patients with left ventricular assist devices.

Fardman A, Kodesh A, Siegel AJ, Segev A, Regev E, Maor E, Berkovitch A, Kuperstein R, Morgan A, Nahum E, Peled Y, Grupper A. Fardman A, et al. Among authors: regev e. Artif Organs. 2024 Aug;48(8):902-911. doi: 10.1111/aor.14733. Epub 2024 Feb 26. Artif Organs. 2024. PMID: 38409872

2

Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement.

Berkovitch A, Segev A, Barbash I, Grossman Y, Maor E, Erez A, Regev E, Fink N, Mazin I, Hamdan A, Goldenberg I, Hay I, Spiegelstien D, Guetta V, Fefer P. Berkovitch A, et al. Among authors: regev e. Cardiovasc Diabetol. 2015 Oct 1;14:131. doi: 10.1186/s12933-015-0291-3. Cardiovasc Diabetol. 2015. PMID: 26427368 Free PMC article.

3

Chewing versus Swallowing Ticagrelor to Accelerate Platelet Inhibition in Acute Coronary Syndrome - the CHEERS study. For The PLATIS (Platelets and Thrombosis in Sheba) Study Group.

Asher E, Frydman S, Katz M, Regev E, Sabbag A, Mazin I, Abu-Much A, Kukuy A, Mazo A, Erez A, Berkovitch A, Narodistky M, Barbash I, Segev A, Beigel R, Matetzky S. Asher E, et al. Among authors: regev e. Thromb Haemost. 2017 Apr 3;117(4):727-733. doi: 10.1160/TH16-09-0728. Epub 2017 Feb 2. Thromb Haemost. 2017. PMID: 28150850 Clinical Trial.

4

Addition of albumin to Traditional Risk Score Improved Prediction of Mortality in Individuals Undergoing Transcatheter Aortic Valve Replacement.

Grossman Y, Barbash IM, Fefer P, Goldenberg I, Berkovitch A, Regev E, Fink N, Ben-Zekry S, Brodov Y, Kogan A, Guetta V, Raanani E, Segev A. Grossman Y, et al. Among authors: regev e. J Am Geriatr Soc. 2017 Nov;65(11):2413-2417. doi: 10.1111/jgs.15070. Epub 2017 Sep 23. J Am Geriatr Soc. 2017. PMID: 28941287

5

Favorable Short-Term and Long-Term Outcomes Among Patients With Prior History of Malignancy Undergoing Transcatheter Aortic Valve Implantation.

Berkovitch A, Guetta V, Barbash IM, Fink N, Regev E, Maor E, Vered Y, Grossman Y, Younis A, Kuperstein R, Feinberg M, Asher E, Segev A, Fefer P. Berkovitch A, et al. Among authors: regev e. J Invasive Cardiol. 2018 Mar;30(3):105-109. J Invasive Cardiol. 2018. PMID: 29493511 Free article.

6

Clinical Outcome and Safety of Transcaval Access for Transcatheter Aortic Valve Replacement as Compared to Other Alternative Approaches.

Barbash IM, Segev A, Berkovitch A, Fefer P, Maor E, Elian D, Regev E, Guetta V. Barbash IM, et al. Among authors: regev e. Front Cardiovasc Med. 2021 Sep 22;8:731639. doi: 10.3389/fcvm.2021.731639. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34631831 Free PMC article.

7

Hemodynamic Changes After Left Ventricular Assist Device Implantation Among Heart Failure Patients With and Without Elevated Pulmonary Vascular Resistance.

Grupper A, Mazin I, Faierstein K, Kurnick A, Maor E, Elian D, Barbash IM, Guetta V, Regev E, Morgan A, Segev A, Lavee J, Fefer P. Grupper A, et al. Among authors: regev e. Front Cardiovasc Med. 2022 Apr 26;9:875204. doi: 10.3389/fcvm.2022.875204. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35557518 Free PMC article.

8

Left atrial size predicts long-term outcome after balloon mitral valvuloplasty.

Canetti M, Kuperstein R, Cohen I, Raibman-Spector S, Maor E, Hai I, Barbash IM, Regev E, Butnaru A, Segev A, Guetta V, Fefer P. Canetti M, et al. Among authors: regev e. Cardiol J. 2023;30(5):753-761. doi: 10.5603/CJ.a2022.0092. Epub 2022 Oct 6. Cardiol J. 2023. PMID: 36200547 Free PMC article.

9

Balloon dilatation and outcome among patients undergoing trans-femoral aortic valve replacement.

Fink N, Segev A, Kornowski R, Finkelstein A, Assali A, Rozenbaum Z, Vaknin-Assa H, Halkin A, Fefer P, Ben-Shoshan J, Regev E, Konigstein M, Orvin K, Guetta V, Barbash IM. Fink N, et al. Among authors: regev e. Int J Cardiol. 2017 Mar 1;230:537-541. doi: 10.1016/j.ijcard.2016.12.062. Epub 2016 Dec 21. Int J Cardiol. 2017. PMID: 28040286

10

Comparison of Outcome of Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis in 3 Age Groups (≤70; 71 to 80, and ≥81 Years).

Regev E, Finkelstein A, Assali A, Barbash I, Fefer P, Ben-Shoshan J, Orvin K, Konigstein M, Guetta V, Kornowski R, Segev A. Regev E, et al. Am J Cardiol. 2017 Nov 1;120(9):1607-1611. doi: 10.1016/j.amjcard.2017.07.060. Epub 2017 Aug 1. Am J Cardiol. 2017. PMID: 28888407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters